OPIS Europe is a clinical research organization (CRO) based in Stockholm, specializing in providing services for clinical trials across Europe. The organization focuses on supporting pharmaceutical and biotechnology companies in the development of new drugs and therapies. OPIS Europe offers a range of services, including study design, project management, regulatory affairs, and data management, ensuring compliance with European regulations and standards.
The company is involved in various phases of clinical research, from early-phase studies to late-phase trials. By leveraging its expertise in clinical operations and regulatory processes, OPIS Europe aims to facilitate the efficient and effective conduct of clinical trials. This includes working closely with investigators and healthcare professionals to ensure that studies are executed smoothly and that data collected is reliable and valid.
In addition to its core services, OPIS Europe emphasizes the importance of patient safety and ethical considerations in clinical research. The organization is committed to adhering to Good Clinical Practice (GCP) guidelines and maintaining high standards of quality throughout the research process. Through its operations, OPIS Europe contributes to the advancement of medical science and the development of new treatment options for patients.